PE-backed Nycomed falls short in pharma bid
PE-backed Nycomed was offering to pay between $5.9B and $6.6B, partly financed by debt lending
12 October 2009•2 mins read
PE-backed Nycomed was offering to pay between $5.9B and $6.6B, partly financed by debt lending